Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-10-001904
Filing Date
2010-01-13
Accepted
2010-01-13 21:44:41
Documents
2
Period of Report
2010-01-11

Document Format Files

Seq Description Document Type Size
1 v171370_ex.html 4  
1 v171370_ex.xml 4 3629
2 ex24.htm EX-24 9278
  Complete submission text file 0001144204-10-001904.txt   14630
Mailing Address 350 CORPORATE BLVD ROBBINSVILLE NJ 08691
Business Address 350 CORPORATE BLVD ROBBINSVILLE NJ 08691 6092089688
NEXMED INC (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIO-QUANT, INC. 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO CA 92121
Business Address
Crea Roberto (Reporting) CIK: 0001478734 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 10526340